Management of diabetes in pregnancy

Jerasimos Ballas1, Thomas R Moore, Gladys A Ramos

  • 1Reproductive Medicine Department, University of California San Diego, 200 West Arbor Drive, San Diego, CA, USA.

Current Diabetes Reports
|December 6, 2011
PubMed

Insights

Diabetes in pregnancy significantly impacts maternal and fetal health, leading to complications like congenital anomalies and stillbirth. New screening guidelines aim to mitigate these risks associated with hyperglycemia during gestation.

Area of Science:

  • Obstetrics and Gynecology
  • Endocrinology
  • Neonatal Medicine

Background:

  • The association between diabetes and adverse pregnancy outcomes is extensively documented.
  • Diabetes in pregnant individuals affects multiple maternal organ systems.
  • In utero exposure to diabetes can cause fetal anomalies, overgrowth, stillbirth, and metabolic issues extending into later life.

Purpose of the Study:

  • To highlight the latest guidelines for screening diabetes in pregnancy.
  • To review the impact of these guidelines on maternal and neonatal complications.
  • To address hyperglycemia in pregnancy and its associated risks.

Main Methods:

  • Review of current literature on diabetes screening in pregnancy.
  • Analysis of recent guideline updates.
  • Examination of maternal and neonatal outcomes related to gestational hyperglycemia.

Main Results:

  • Updated screening guidelines offer a framework for early detection of diabetes in pregnancy.
  • Implementation of new guidelines may influence the incidence of maternal and neonatal complications.
  • Understanding the long-term metabolic effects on offspring exposed to maternal diabetes is crucial.

Conclusions:

  • Adherence to updated screening protocols is vital for managing diabetes in pregnancy.
  • Early identification and management of hyperglycemia can potentially reduce adverse maternal and fetal outcomes.
  • Further research is needed to fully elucidate the long-term impact of in utero diabetic exposure on offspring health.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...